| 臺大學術典藏 |
2022-05-11T07:47:52Z |
The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression
|
Kuo Y.-Y.; Hou H.-A.|YIN-KAI CHEN; Li L.-Y.; Chen P.-H.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Chou W.-C.; Liu C.-Y.; Tang J.-L.; Yao M.; Tien H.-F. |
| 臺大學術典藏 |
2022-05-11T07:47:51Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
YIN-KAI CHEN; Hou H.-A.; Tang J.-L.; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-25T07:36:14Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; JIA-HAU LIU; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-25T07:36:12Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
Tien F.-M.; Tsai C.-H.; Huang S.-C.; JIA-HAU LIU; Chen C.-Y.; Kuo Y.-Y.; Chuang Y.-K.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Wu Y.-S.; Hou M.-F.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Chou W.-C.; Yao M.; Hou H.-A.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-25T03:57:25Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai C.-H;Tang J.-L;Tien F.-M;Kuo Y.-Y;Wu D.-C;Lin C.-C;Tseng M.-H;Peng Y.-L;Hou M.-F;Chuang Y.-K;Liu M.-C;Liu C.-W;Yao M;Lin L.-I;Chou W.-C;Chen C.-Y;Hou H.-A;Tien H.-F.; Tsai C.-H; Tang J.-L; Tien F.-M; Kuo Y.-Y; Wu D.-C; Lin C.-C; Tseng M.-H; Peng Y.-L; Hou M.-F; Chuang Y.-K; Liu M.-C; Liu C.-W; Yao M; Lin L.-I; Chou W.-C; Chen C.-Y; Hou H.-A; Tien H.-F.; CHIEN-YU CHEN |
| 臺大學術典藏 |
2022-04-14T07:20:27Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
FENG-MING TIEN; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:27Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
FENG-MING TIEN; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Yao M.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:26Z |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Tsai C.-H.; Yao C.-Y.; FENG-MING TIEN; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:26Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
FENG-MING TIEN; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:23Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai C.-H.; Tang J.-L.; FENG-MING TIEN; Kuo Y.-Y.; Wu D.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F. |
